Abbott Plans to Spin Off Its Nutrition Business
What happened
- Abbott intends to separate its global Nutrition business into an independent, publicly traded company distributed to Abbott shareholders.
- The Nutrition company is expected to have approximately $8.5 billion in annual sales and brands including Ensure, PediaSure, Glucerna, Similac and Pedialyte.
- Abbott expects to complete the separation by the end of 2027, subject to regulatory approvals, a Form 10 registration statement and final board approval.
Why it matters
The planned spin-off would create a separately traded nutrition company while leaving Abbott focused on medical devices, diagnostics and established medicines. It is relevant to healthcare investors and corporate-finance professionals assessing portfolio focus, capital allocation and separation execution.
What to watch. Regulatory approvals, effectiveness of the Form 10 registration statement, final Abbott board approval and completion by the end of 2027.
Deal terms
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
Timeline
- EarlierOct 18Tokenized stock trading takes off overseas as Goldman, other U.S. companies object
- EarlierOct 19Indonesian Stocks Tumble to Lowest Since 2020 After MSCI Warning
- EarlierOct 21Goldman Sachs Says War Spurs Sevenfold Jump in Oil Freight Rates
- First reported by PR NewswireOct 21Abbott announces its intention to separate its global Nutrition business into an independent, publicly traded company
- Bloomberg reportsOct 21Abbott Plans to Spin Off Its Nutrition Business
- The Wall Street Journal reportsOct 21Abbott to Carve Out Nutrition Business Into Independent Company
- Financial Times reportsOct 21Abbott to spin off nutrition unit at centre of baby formula lawsuits
- MedTech Dive reportsOct 21Abbott plans to spin out its nutrition business
- Food Dive reportsOct 21Abbott plans to spin out its nutrition business
Who is involved
Sources (6)
- PR NewswireOct 21Abbott announces its intention to separate its global Nutrition business into an independent, publicly traded company
- BloombergOct 21Abbott Plans to Spin Off Its Nutrition Business
- The Wall Street JournalOct 21Abbott to Carve Out Nutrition Business Into Independent Company
- Financial TimesOct 21Abbott to spin off nutrition unit at centre of baby formula lawsuits
- MedTech DiveOct 21Abbott plans to spin out its nutrition business
- Food DiveOct 21Abbott plans to spin out its nutrition business
Related
- 11h · Goldman Cuts Kospi 12-Month Target by 25% as AI Trade Unravels
- Oct 22 · SpaceX $40 billion debt deal gets pricey as AI fears spread
- Oct 23 · Hedge Funds Log Widest Daily Drawdown Since Covid in Stock Rout
- Oct 19 · Indonesian Stocks Tumble to Lowest Since 2020 After MSCI Warning
- Oct 21 · Goldman Sachs Says War Spurs Sevenfold Jump in Oil Freight Rates
- Oct 18 · Tokenized stock trading takes off overseas as Goldman, other U.S. companies object
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
- Why it matters to youEvery story matched to your watchlist, your contacts and your pipeline.
- Follow developing storiesAn alert, and a push, the moment a story you follow moves.
- Your briefing, read aloudA few minutes each morning with a chapter per story.
- Brief modeSwipe through the day, a 20-second card each.